Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy
Annals of Neurology · 2024
DOI: 10.1002/ana.26902 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Neurology, 2024. Verfasst von Dario Arnaldi und 44 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: REM Sleep Behavior Disorder, Synucleinopathies, Lewy Body Disease, Parkinson Disease. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for the National Institutes of Health, Monument Trust Discovery Award from Parkinson's UK, NIA NIH HHS.
Abstract (Originalsprache)
Objective
To apply a machine learning analysis to clinical and presynaptic dopaminergic imaging data of patients with rapid eye movement (REM) sleep behavior disorder (RBD) to predict the development of Parkinson disease (PD) and dementia with Lewy bodies (DLB). Method s In this multicenter study of the International RBD study group, 173 patients (mean age 70.5 ± 6.3 years, 70.5% males) with polysomnography‐confirmed RBD who eventually phenoconverted to overt alpha‐synucleinopathy (RBD due to synucleinopathy) were enrolled, and underwent baseline presynaptic dopaminergic imaging and clinical assessment, including motor, cognitive, olfaction, and constipation evaluation. For comparison, 232 RBD non‐phenoconvertor patients (67.6 ± 7.1 years, 78.4% males) and 160 controls (68.2 ± 7.2 years, 53.1% males) were enrolled. Imaging and clinical features were analyzed by machine learning to determine predictors of phenoconversion.
Results
Machine learning analysis showed that clinical data alone poorly predicted phenoconversion. Presynaptic dopaminergic imaging significantly improved the prediction, especially in combination with clinical data, with 77% sensitivity and 85% specificity in differentiating RBD due to synucleinopathy from non phenoconverted RBD patients, and 85% sensitivity and 86% specificity in discriminating PD‐converters from DLB‐converters. Quantification of presynaptic dopaminergic imaging showed that an empirical z ‐score cutoff of −1.0 at the most affected hemisphere putamen characterized RBD due to synucleinopathy patients, while a cutoff of −1.0 at the most affected hemisphere putamen/caudate ratio characterized PD‐converters.
Interpretation
Clinical data alone poorly predicted phenoconversion in RBD due to synucleinopathy patients. Conversely, presynaptic dopaminergic imaging allows a good prediction of forthcoming phenoconversion diagnosis. This finding may be used in designing future disease‐modifying trials. ANN NEUROL 2024;95:1178–1192
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Neurology Service, Sleep Disorder Centre, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, CIBERNED: CB06/05/0018-ISCIII, Barcelona, Spain.
- Nuclear Medicine Service, Hospital Clínic Barcelona, Biomedical Research Networking Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), ISCIII, Barcelona, Spain.
- Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
- Sleep Medicine Center, Neurology Unit, University Hospital of Rome Tor Vergata, Rome, Italy.
ORCID-Profile: Dario Arnaldi, Federico Massa, Alex Iranzo, Claudio Liguori, Tomoyuki Miyamoto, Dieter Kunz, Elena Antelmi, Michele Terzaghi
Förderung
- Foundation for the National Institutes of Health
- Monument Trust Discovery Award from Parkinson's UK
- NIA NIH HHS
- Slovak Scientific Grant Agency
- Ministero della Salute
- GE Healthcare
- Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program
- National Institute for Neurological Research
Zitieren
APA
Arnaldi, D., Mattioli, P., Raffa, S., Pardini, M., Massa, F., Iranzo, A., Perissinotti, A., Niñerola-Baizán, A., Gaig, C., Serradell, M., Muñoz-Lopetegi, A., Mayà, G., Liguori, C., Fernandes, M., Placidi, F., Chiaravalloti, A., Šonka, K., Dušek, P., Zogala, D., …, & International REM Sleep Behavior Disorder Study Group (2024). Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy. Annals of Neurology. https://doi.org/10.1002/ana.26902
Vancouver
Arnaldi D, Mattioli P, Raffa S, Pardini M, Massa F, Iranzo A, et al. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy. Annals of Neurology. 2024. doi:10.1002/ana.26902
BibTeX
@article{Arnaldi2024,
author = {Arnaldi, Dario and Mattioli, Pietro and Raffa, Stefano and Pardini, Matteo and Massa, Federico and Iranzo, Alex and Perissinotti, Andres and Niñerola-Baizán, Aida and Gaig, Carles and Serradell, Monica and Muñoz-Lopetegi, Amaia and Mayà, Gerard and Liguori, Claudio and Fernandes, Mariana and Placidi, Fabio and Chiaravalloti, Agostino and Šonka, Karel and Dušek, Petr and Zogala, David and Trnka, Jiri and Boeve, Bradley F and Miyagawa, Toji and Lowe, Val J and Miyamoto, Tomoyuki and Miyamoto, Masayuki and Puligheddu, Monica and Figorilli, Michela and Serra, Alessandra and Hu, Michele T and Klein, Johannes C and Bes, Frederik and Kunz, Dieter and Cochen De Cock, Valérie and de Verbizier, Delphine and Plazzi, Giuseppe and Antelmi, Elena and Terzaghi, Michele and Bossert, Irene and Kulcsárová, Kristína and Martino, Alessio and Giuliani, Alessandro and Pagani, Marco and Nobili, Flavio and Morbelli, Silvia and International REM Sleep Behavior Disorder Study Group, International REM Sleep Behavior Disorder Study Group},
title = {Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy},
journal = {Annals of Neurology},
year = {2024},
doi = {10.1002/ana.26902}
}
EUVIMED